Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

BACKGROUND AND OBJECTIVES: Volixibat is a potent inhibitor of the apical sodium-dependent bile acid transporter in development for the treatment of nonalcoholic steatohepatitis. This phase 1, open-label study investigated the absorption, distribution, metabolism, and excretion of [(14)C]-volixibat i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Drug Metab Pharmacokinet
Huvudupphovsmän: Siebers, Nicholas, Palmer, Melissa, Silberg, Debra G., Jennings, Lee, Bliss, Caleb, Martin, Patrick T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2017
Ämnen:
Original Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5794849/
https://ncbi.nlm.nih.gov/pubmed/28702877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-017-0429-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk